BRUCE PECORELLA: Open Payments
NPI 1184718801 · OSWEGO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,926 in 106 payments from 32 companies in 2025. Trend: 2023 $1,659 · 2024 $2,136 · 2025 $1,926
Food & beverage: $1,926
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $335 |
| AstraZeneca Pharmaceuticals LP | 12 | $205 |
| Verona Pharma, Inc. | 8 | $147 |
| Otsuka America Pharmaceutical, Inc. | 5 | $111 |
| Vanda Pharmaceuticals Inc. | 4 | $110 |
| Exact Sciences Corporation | 4 | $98 |
| GlaxoSmithKline, LLC. | 5 | $94 |
| Corcept Therapeutics | 4 | $80 |
| Abbott Laboratories | 4 | $74 |
| Lilly USA, LLC | 2 | $53 |
Products named: VRAYLAR, AIRSUPRA, Ohtuvayre, REXULTI, HETLIOZ, The Cologuard Plus Collection Kit, TRELEGY ELLIPTA, Korlym.
Industry payments across NY — which companies pay providers there.
